Markets News
Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.
Indian Markets Plunge: Sensex Down 1,000 Points; Nifty Breaks 24,000
Indian shares tumbled on Friday with the Sensex falling over 1,000 points and the Nifty 50 slipping below 23,900, driven by rising oil prices and weak tech earnings.
ASX 200 Extends Losing Streak as Oil Tensions Divide Market Ahead of RBA Decision
Australian shares fell for a fourth straight session, with the ASX 200 down 0.1% to 8,786.5 as oil above $105 a barrel fueled a rotation into energy and utilities. Suncorp gained 4.9% on a new reinsurance deal, while IGO slumped 17.3% on lower production guidance.
Old Republic International: Undervalued Amid Digital Transformation and Market Risks
Old Republic International (ORI) closed at $39.90, below its $42.50 fair value, as the insurer focuses on digitalization and AI to improve efficiency and margins. Risks include title insurance volatility and weaker real estate activity.
Expedia Shares Tumble on CFO Transition Ahead of Earnings
Expedia Group names former Snap CFO Derek Andersen as its next finance chief, effective May 11. Shares fall 5.4% as investors digest the leadership change ahead of earnings.
SolarEdge Surges 11% on New Battery Launch, But Wall Street Remains Wary
SolarEdge shares surged 11% to $47.36 on Thursday after launching a 197 kWh commercial battery system. Despite 2025 revenue rising 31%, the company posted a net loss of $405.4 million and analysts remain bearish with a $29.90 target.
Lucid Shares Slide 9.6% as Uber Stake Fails to Calm Funding Fears
Lucid Group shares dropped 9.6% after Uber disclosed an 11.52% stake, as a $1.05 billion capital raise and partnership news failed to ease investor worries about liquidity and production.
Netflix Unveils $25 Billion Buyback After Failed Warner Bros Tie-Up
Netflix approved a $25 billion buyback, adding to $6.8 billion remaining, after pocketing a $2.8 billion breakup fee from a collapsed Warner Bros deal.
Hims Expands Branded GLP-1 Access with Lilly's Zepbound and Foundayo
Hims & Hers Health now offers Eli Lilly's Zepbound and Foundayo via LillyDirect, broadening its branded GLP-1 lineup amid a competitive cash-pay market.
